Toll Brothers
TOL
Meritage Homes
MTH
Taylor Morrison Home
TMHC
D.R. Horton
DHI
KB Home
KBH
US Stock MarketDetailed Quotes
BLRX BioLine Rx
- 0.143
- -0.017-10.88%
Close Jan 8 16:00 ET
- 0.142
- 0.000-0.21%
Post 19:59 ET
11.99MMarket Cap-0.48P/E (TTM)
0.162High0.135Low15.13MVolume0.162Open0.160Pre Close2.20MTurnover19.65%Turnover RatioLossP/E (Static)84.11MShares1.44052wk High1.41P/B10.98MFloat Cap0.13552wk Low--Dividend TTM77.00MShs Float103.050Historical High--Div YieldTTM16.75%Amplitude0.135Historical Low0.145Avg Price1Lot Size
About BioLine Rx Company
BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors. The company was founded in 2003 and is headquartered in Modi'in, Israel.
Company Profile
SymbolBLRX
Company NameBioLine Rx
Listing DateJul 25, 2011
Founded2003
CEOMr. Philip A. Serlin, C.P.A.,M.B.A.
MarketNASDAQ
Employees79
Securities TypeDR
ADS Ratio1.0 : 15.0
Fiscal Year Ends12-31
AddressModi'in Technology Park,2 HaMa'ayan Street
CityModi'in
ProvinceHaMerkaz
CountryIsrael
Zip Code7177871
Phone972-8-642-9100
Websitehttp://www.biolinerx.com
Company Executives
- Name
- Position
- Salary
- Philip A. Serlin, C.P.A.,M.B.A.
- Chief Executive Officer
- 952.00K
- Mali Zeevi, C.P.A.
- Chief Financial Officer
- 443.00K
- Dr. Ella Sorani, PhD
- Chief Development Officer
- 520.00K
- Holly W. May, M.B.A.
- President, US
- 1.01M
- Dr. Aharon Schwartz,PhD
- Chairman of the Board
- --
- Dr. Shaoyu Yan, PhD
- Director
- --
- Dr. Sandra Panem,PhD
- Independent Director
- --
- Dr. Raphael Hofstein, PhD
- Independent Director
- --
- Rami Dar, M.B.A.
- Independent Director
- --
- Dr. B. J. Bormann, PhD
- Independent Director
- --
- Dr. Avraham Molcho, M.D.
- Independent Director
- --
- Gal Cohen
- Independent Director
- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.